Compare Starbucks Corp (SBUX) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Starbucks Corp vs Tenet Healthcare Corporation — how do they compare? Starbucks Corp trades at $93.14 (market cap $106.68B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Starbucks Corp is far larger — about 5.1× Tenet Healthcare Corporation's market cap, and Starbucks Corp pays a 2.65% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Starbucks Corp for 190 Days and Tenet Healthcare Corporation for 15 Days on average.
| SBUX | THC | |
|---|---|---|
Market Cap | $106.68B | $20.92B |
Volume | 9,406,993 | 455,764 |
Sector | Consumer Cyclical | Health |
52-Week High | $108.55 | $280.77 |
52-Week Low | $78.46 | $161.37 |
Typical Hold Time | 190 Days | 15 Days |
Enterprise Value | $125.51B | $32.00B |
Dividend Yield | 2.65% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Starbucks (SBUX) trades at $93.58, down 2.63% amid bearish technical signals and recent store closure announcements. The company shows mixed fundamentals with a high P/E ratio of 54.09 but strong recent earnings beats. Revenue growth remains modest at $37.18B for 2025, while net income declined to $1.86B. Analyst consensus remains positive with a $115.50 price target despite ongoing restructuring challenges and geopolitical tensions in China operations.
The stock faces near-term pressure from operational restructuring but maintains long-term growth potential through international expansion and brand strength. Key risks include labor relations, Chinese market exposure, and execution of store optimization strategy. With 47% analyst buy ratings and solid dividend payments, SBUX offers value for patient investors despite current headwinds.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Starbucks Corp
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
